Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 968 across all filing types
Latest filing 2025-08-04 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
募集资金管理制度
Capital/Financing Update Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System' and details the management, use, supervision, and regulatory compliance related to the company's raised funds. It extensively discusses the procedures, approvals, and controls for the use of funds raised through stock issuance or equity securities. The document is a policy or internal management system document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results but rather governance and procedural rules regarding capital raised. This fits best under the category of Capital/Financing Update (CAP), as it relates to the management and use of capital raised by the company. The document length (8702 characters) and content confirm it is a substantive policy document, not a brief announcement or certification. Therefore, the classification is CAP with high confidence.
2025-08-04 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is titled '监事会决议公告' which translates to 'Supervisory Board Resolution Announcement'. It details the resolutions passed by the supervisory board during their meeting on August 4, 2025. The resolutions include approval of the 2025 semi-annual report and its summary, changes to the company's business scope and articles of association, and the abolition of certain supervisory meeting rules. The document states that the actual reports and detailed announcements are available on the official disclosure website, indicating this document is an announcement of resolutions rather than the full report itself. The document length is short (1410 characters), and it primarily serves to announce supervisory board decisions and related voting results. This fits best with the category of Regulatory Filings (RNS), as it is a general regulatory announcement and does not contain the full financial report or detailed financial data itself.
2025-08-04 Chinese
独立董事工作制度
Governance Information Classification · 100% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System' and contains detailed rules and regulations regarding the roles, responsibilities, nomination, election, rights, and obligations of independent directors within the company. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission and Shenzhen Stock Exchange. The content is a governance framework document rather than a financial report, announcement, or meeting material. It does not contain financial data, earnings, voting results, or legal proceedings. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-04 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a '2025 年半年度报告摘要' which translates to '2025 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes operational and business updates, product development progress, and management commentary on performance and outlook. The length of the document (5652 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive interim report rather than a brief announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-04 Chinese
重大信息内部报告制度
Governance Information Classification · 95% confidence The document is titled '重大信息内部报告制度' which translates to 'Major Information Internal Reporting System'. It outlines the internal procedures and responsibilities for reporting major information within the company, including definitions of what constitutes major information, reporting obligations, and management responsibilities. The content is regulatory and procedural in nature, focusing on internal governance and compliance with disclosure laws. It does not contain financial statements, earnings data, or direct announcements of financial results. It is not a report of financial performance or an announcement of voting results, nor is it a transcript or presentation. The document is a governance-related internal policy document detailing the company's internal rules and procedures for information disclosure and reporting. Therefore, it fits best under Governance Information (CGR). The document length (7754 characters) and detailed procedural content support this classification with high confidence.
2025-08-04 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is titled '信息披露管理制度' which translates to 'Information Disclosure Management System' for 烟台正海生物科技股份有限公司. It extensively details the company's policies, procedures, and responsibilities regarding information disclosure, including legal compliance, internal controls, reporting obligations, confidentiality, and management of disclosures. It references regulatory frameworks such as the Chinese Company Law, Securities Law, and Shenzhen Stock Exchange rules. The document is a comprehensive internal governance and compliance manual for managing information disclosure rather than a financial report, earnings release, or announcement. It does not contain financial statements, audit opinions, or event-specific disclosures but rather outlines the rules and processes for disclosure. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices related to disclosure and compliance.
2025-08-04 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.